AMBUL EXPANDS NEUROLOGY PORTFOLIO IN NORTH AMERICA AND EUROPE

Ambu Expands Neurology Portfolio in North America and Europe

Posted by Ambu A/S on August 20, 2026

-------- Original Version -----------

Ambu expands its neurology portfolio with an EEG solution that supports continued brain monitoring during MRI/CT scans, following FDA clearance and CE marking for Ambu® Neuroline™ Cup MRI/CT.

-------- English Version ------------

Ambu expands its neurology portfolio with an EEG solution supporting continued brain monitoring during MRI/CT scans, following FDA clearance and CE marking for Ambu® Neuroline™ Cup MRI/CT.

-------- Link if available ----------

No Link available